Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

June’s top stories: Takeda and Biological E. collaborated, J&J completed Actelion acquisition

Takeda and Biological E. collaborated to develop affordable combination vaccines, and J&J completed the Actelion acquisition for $30bn. wraps up the key headlines from June.

Go Top